Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1742927 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.44Day +6.71%Mkt cap $6M1Y −95.2%Off 52W high −97.5%Vol (1Y) 168.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,364 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.3% of sh out |
| Days to cover3.7d |
| 13F net flow (QoQ)−0.22% |
| Top-10 13F concentration95.9% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$16.6M |
| ROE−420.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−92.2% |
| 1Y−95.2% |
| 3Y−99.5% |
| 5Y−99.4% |
| Since incept. (ann.)−66.6% |
Total return through 2026-07-30 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)168.6% |
| Ann. volatility (3Y)143.0% |
| Sharpe (1Y)−0.86 |
| Sharpe (3Y)−0.48 |
| Max drawdown (1Y)−98.0% |
| Max drawdown (3Y)−99.7% |
| Beta (3Y vs SPY)0.94 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 793,948 | $579,344 | 6.20% | new |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 762,236 | $556,204 | 5.95% | new |
| ARMISTICE CAPITAL, LLC | 592,079 | $432,040 | 4.62% | new |
| GSA CAPITAL PARTNERS LLP | 261,898 | $191,000 | 2.04% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 117,568 | $85,825 | 0.92% | new |
| Warberg Asset Management LLC | 90,772 | $66,218 | 0.71% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 72,992 | $53,265 | 0.57% | new |
| RENAISSANCE TECHNOLOGIES LLC | 43,002 | $31,379 | 0.34% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for RVPH.
